Denise Chow1, Larissa V Rodríguez. 1. Department of Urology and Obstetrics and Gynecology, University of California, Los Angeles, California 90024, USA. dchow@mednet.ucla.edu
Abstract
PURPOSE OF REVIEW: The purpose of this review is to discuss the epidemiology and prevalence of pelvic organ prolapse. RECENT FINDINGS: There will be an increase in demand for pelvic floor treatment as the aging population increases in number. Identification of modifiable risk factors may help in patient counseling and prevention in patients at risk for developing pelvic organ prolapse. SUMMARY: As the elderly population is expected to double in number by the year 2030, pelvic organ prolapse will become more prevalent. To allocate resources to the increasing number of female patients who will present to healthcare providers with pelvic organ prolapse, we need a better understanding of its incidence, risk factors, prevalence, natural history, clinical implications, and treatment options. This understanding will not only improve our ability to treat this growing patient population but will also help us develop preventive strategies to ameliorate patients' suffering from this condition.
PURPOSE OF REVIEW: The purpose of this review is to discuss the epidemiology and prevalence of pelvic organ prolapse. RECENT FINDINGS: There will be an increase in demand for pelvic floor treatment as the aging population increases in number. Identification of modifiable risk factors may help in patient counseling and prevention in patients at risk for developing pelvic organ prolapse. SUMMARY: As the elderly population is expected to double in number by the year 2030, pelvic organ prolapse will become more prevalent. To allocate resources to the increasing number of female patients who will present to healthcare providers with pelvic organ prolapse, we need a better understanding of its incidence, risk factors, prevalence, natural history, clinical implications, and treatment options. This understanding will not only improve our ability to treat this growing patient population but will also help us develop preventive strategies to ameliorate patients' suffering from this condition.
Authors: S Albrich; K Rommens; J Steetskamp; V Weyer; G Hoffmann; C Skala; E Zahn Journal: Geburtshilfe Frauenheilkd Date: 2015-01 Impact factor: 2.915
Authors: Emily A Slopnick; Andrey Petrikovets; David Sheyn; Simon P Kim; Carvell T Nguyen; Adonis K Hijaz Journal: Int Urogynecol J Date: 2018-10-03 Impact factor: 2.894
Authors: Ana Isabel López-López; Javier Sanz-Valero; Luis Gómez-Pérez; Maria Pastor-Valero Journal: Int Urogynecol J Date: 2020-10-17 Impact factor: 2.894
Authors: Laura B Huffman; Laura K Randolph; Georgia A McCann; Caroline Billingsley; Michael P Hopkins; David E Cohn; Andrew F Hundley Journal: Gynecol Oncol Case Rep Date: 2013-10-16